Skip to main content

Advertisement

Table 2 Antibiotic susceptibility data of Cellulosimicrobium species (or Oerskovia) in reported cases

From: Infections due to Cellulosimicrobium species: case report and literature review

  All species C. cellulans C. funkei
No. of isolates MIC range (mg/L) % Susceptibility No. of isolates % Susceptibility No. of isolates % Susceptibility
AMC 4 1/0.5–16/8 50% 4 50%
AMK 11 4–16 73% 7 57% 3 100%
CFZ 9 1–8 67% 8 75%
CIP 15 1 - > 8 13% 12 17% 0 0%
CLI 13 2–8 8% 12 0%
CTX 7 8–64 29% 5 20% 2 50%
ERY 19 1–16 26% 13 15% 4 50%
GEN 14 2–16 43% 9 11% 4 100%
IMP 8 <  0.25 - > 16 75% 6 83% 2 50%
LNZ 4 0.5–1 100% 4 100%
PEN 24 0.012–4 25% 17 18% 4 25%
RIF 12 <  0.5–4 75% 9 78% 3 67%
SXT 20 <  0.06/1.19–8/152 85% 15 93% 4 50%
TET 16 1–8 50% 13 54% 2 50%
VAN 30 ≤ 0.25 - < 4 100% 23 100% 5 100%
  1. AMC Amoxicillin-clavulanate, AMK Amikacin, CFZ Cefazolin, CIP Ciprofloxacin, CLI Clindamycin, CTX Cefotaxime, ERY Erythromycin, GEN Gentamycin, IMP Imipenem, LNZ Linezolid,
  2. MIC Minimum inhibitory concentration, PEN Penicillin, RIF Rifampin, SXT Trimetroprim-sulfamethoxazole, TET Tetracycline, VAN Vancomycin